12:00 AM
 | 
Mar 13, 2000
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Immunomedics preclinical data

IMMU researchers reported that RNase coupled to the company's LymphoCide antibody produced a cure rate of 40...

Read the full 62 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >